International Multicenter Study of In-hospital Outcome of Patients After ICU Discharge
NCT ID: NCT02347150
Last Updated: 2015-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2015-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Previous studies have shown that the clinical condition of the patient at the time of ICU discharge may influence in-hospital prognosis. Non-modifiable factors, such as age and comorbid conditions certainly play a role. But inflammatory status (especially C-reactive protein - CRP), Sequential organ failure score (SOFA) score and Therapeutic intervention scoring system (TISS) 28 score have also been related with the risk of hospital death.
Admission to a high dependency unit may reduce the ICU length of stay (LOS). This strategy may also help to improve prognosis contributing to further stabilize the patient, facilitate his autonomy and the removal of invasive devices. However the benefit of a step-down strategy (from ICU to a high dependency unit) has never been evaluated.
The development of a score to evaluate the risk of patients discharged from the ICU may help to improve the allocation of resources, either to prolong the ICU stay, or admission to a high dependency units or the ward.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Survive After ICU Discharge
NCT02599636
Health-related Quality of Life and Functional Impairments After Intensive Care Unit Discharge
NCT05111522
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
NCT04401111
Outcomes and Prognostic Factors in COVID-19
NCT04321265
Evaluation of the Impact of Within-hospital Trajectories of Patients Admitted in Intensive Care Units (ICU) From Emergency Departments
NCT02307136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Exclusion criteria: Limitation of care decision Primary objective: To determine the impact in hospital mortality and LOS (ICU and hospital) of a step-down strategy, from the ICU to a high dependency unit, before admission to the ward.
Secondary objectives: To develop and validate a score of the risk of death in the hospital after discharge from the ICU
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU LOS>24h
30-110 patients discharged from the ICU
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Vila Franca de Xira
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
João Gonçalves-Pereira
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
João Goncalves-Pereira, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Vila Franca de Xira
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Fernando da Fonseca
Amadora, , Portugal
Hospital Nélio Mendonça
Funchal, , Portugal
Hospital Vila Franca de Xira
Vila Franca de Xira, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HVFX01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.